← Leaderboards
Sally J Denardo
University Of California Davis
$2,893,757
Attributed
$2,893,757
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $656.4K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,893,757 · 3
By mechanism
P01$1,468,675 · 2
U19$1,425,082 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Davis
Same institution · by research overlap
- Gerald L Denardo$3,030,924
- Claude F. Meares$5,274,336
- Robert T O'Donnell$706,327
- Carol M. Richman$180,509
- Christine L Hartmann-Siantar$706,984
Others in their field
Top investigators on “Radiotracer”
- Robert H Mach · Wake Forest University$39,562,505
- Simon R Cherry · University Of California Los Angeles$17,948,135
- Joel Synes Perlmutter · Washington University$16,457,601
- Gwenn S Smith · Long Island Jewish Medical Center$16,008,680
- Richard E Carson · Yale University$15,174,693
- Rajesh Narendran · Columbia University Health Sciences$15,115,382
Research focus
RadiotracerAthymic MouseMonoclonal AntibodyImmunoconjugatesImmunologic Substance Development /PreparationDrug Design /Synthesis /ProductionNeoplasm /Cancer RadioimmunotherapyLaboratory MouseChelating AgentsBiomedical FacilityTherapy Design /DevelopmentRadiopharmacologyBaseImmunological SubstanceClassificationImageIn VitroEvaluationDrug KineticsCharacteristicsBiodistributionFutureDosimetryDetection
Grant awards (14)
Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therapeutics$342,735
U19 · FY2009 · CA · contact PI
Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therapeutics$335,155
U19 · FY2008 · CA · contact PI
Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therapeutics$329,758
U19 · FY2007 · CA · contact PI
Novel Approaches to Pretargeted Radioimmunotherapy$274,499
P01 · FY2006 · CA · contact PI
Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therpeutics$217,011
U19 · FY2006 · CA · contact PI
Core--Radiopharmaceutical Development$164,868
P01 · FY2006 · CA · contact PI
Novel Approaches to Pretargeted Radioimmunotherapy$281,730
P01 · FY2005 · CA
Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging and Therpeutics$200,423
U19 · FY2005 · CA
Core--Radiopharmaceutical Development$155,063
P01 · FY2005 · CA
Novel Approaches to Pretargeted Radioimmunotherapy$270,774
P01 · FY2004 · CA
Core--Radiopharmaceutical Development$141,234
P01 · FY2004 · CA
Core--Radiopharmaceutical development$0
P01 · FY2002 · CA
Core--Radiopharmaceutical development$0
P01 · FY2001 · CA
Core--Radiopharmaceutical development$180,507
P01 · FY2000 · CA